Funder
National Institute for Health and Care Excellence
Publisher
Springer Science and Business Media LLC
Reference42 articles.
1. Campbell B, Campbell M. NICE medical technologies guidance: a novel and rigorous methodology to address a new health technology assessment challenge. Appl Health Econ Health Policy. 2012;10:295–7.
2. National Institute for Health and Care Excellence. Medical technologies guidance [Internet]. NICE. NICE. https://www.nice.org.uk/about/what-we-do/our-programmes/nice-guidance/nice-medical-technologies-guidance. Cited 4 Apr 2024.
3. National Institute for Health and Care Excellence. Sedaconda ACD-S for sedation with volatile anaesthetics in intensive care: Supporting documentation [Internet]. 2021: https://www.nice.org.uk/guidance/mtg65/documents/supporting-documentation. Cited 4 Apr 2024.
4. Meiser A, Volk T, Wallenborn J, Guenther U, Becher T, Bracht H, et al. Inhaled isoflurane via the anaesthetic conserving device versus propofol for sedation of invasively ventilated patients in intensive care units in Germany and Slovenia: an open-label, phase 3, randomised controlled, non-inferiority trial. Lancet Respir Med. 2021;9:1231–40.
5. Bellgardt M, Georgevici AI, Klutzny M, Drees D, Meiser A, Gude P, et al. Use of MIRUSTM for MAC-driven application of isoflurane, sevoflurane, and desflurane in postoperative ICU patients: a randomized controlled trial. Ann Intensive Care. 2019;9:118.